Articles examining published human trial data and clinical findings on research peptides — what controlled studies, regulatory reviews, and trial outcomes actually show. Coverage spans approved compounds and those still under investigation, with attention to evidence quality and the gap between preclinical promise and confirmed clinical proof.
What enclomiphene is, how it raises testosterone through the HPG axis, why it differs from TRT on fertility, and its clinical evidence and regulatory status.
What NAD+ is, why its age-related decline matters, how it differs from precursors like NMN and NR, and what human trials have and have not demonstrated.
Does GLP-1 weight loss cause muscle loss? What lean mass measurements actually mean, what newer research suggests, and the strategies studied to preserve it.
What tirzepatide microdosing means, why interest in sub-therapeutic dosing has grown, what the evidence does and does not show, and the open safety questions.
A deeper dive into the two most popular recovery peptides in the research literature. We compare mechanisms, study quality, tissue specificity, and what the combination research suggests.
A detailed research review of the two most commonly paired growth hormone peptides. We cover individual mechanisms, the rationale for combining them, and what clinical data exists.
Two peptides from the same family that took very different paths. Melanotan II tans skin and boosts libido, while PT-141 became an FDA-approved drug. We cover the melanocortin science behind…
Two brain-boosting peptides developed by Russian scientists. We look at the published research on Selank for anxiety and Semax for cognition, and what Western science makes of these compounds.
GLP-1 drugs went from diabetes treatment to cultural phenomenon. We trace the science behind the incretin revolution, from the Gila monster discovery to the billion-dollar drugs reshaping medicine.
The only FDA-approved peptide for sexual desire. We break down the clinical trials behind PT-141, how it works through melanocortin receptors in the brain, and what the data says about…
From telomere extension to skin repair, multiple peptides are being studied for anti-aging effects. We sort through the evidence and separate the promising leads from the hype.
The only FDA-approved GHRH analog specifically shown to reduce visceral belly fat. We cover the clinical trial evidence, how it works differently from other GH peptides, and its safety record.
The STEP trial program put semaglutide through rigorous testing across different patient groups. Here is a breakdown of the weight loss results, side effects, and what happened after people stopped…
BPC-157 is one of the most studied recovery peptides in animal research. We cover what scientists have found about gut healing, tendon repair, and tissue protection.
The SURPASS trials tested tirzepatide across thousands of diabetes patients. Here is what the data actually showed for blood sugar control, weight loss, and how it stacked up against insulin.
A new peptide that hits three receptors instead of two. Early trial data suggests it could produce even more weight loss than tirzepatide. We look at what the Phase 2…
Join our newsletter for weekly peptide research updates, new study summaries, and exclusive content delivered to your inbox.
